Background: Reticulate acropigmentations of Kitamura (RAPK) is an autosomal dominant inherited disorder characterized by pigmented, angulated, irregular freckle-like lesion with atrophy on the surface, arranged in a reticulate pattern on the dorsa of the hands and feet. It was first described by Kitamura and Akamatsu in Japan in 1943. The usual age of onset is the first and second decades of life. Palms and soles reveal pits and breaks in the epidermal ridge pattern. The histopathological examination show epidermal atrophy, digitate and filiform elongated rete ridges with clumps of heavy melanin pigmentation at their tips.
Introduction
Reticulated acropigmentation of Kitamura (RAPK) is an autosomal dominant inherited dermatoses first reported in 1943 by Kitamura and Akamatsu in Japan. The majority of reported cases occur in Japanese patients, but the condition has also been recognized worldwide. We report a case of RAPK without the involvement of the palms and soles.
Case report
A 59-year-old male presented with symptomless and symmetrically progressive brownish-black discoloration, forming a reticulate pattern on the dorsal aspect of his hands and feet. The macules appeared ten years ago. It was not preceded by any inflammatory dermatoses. Over the years, the macules had progressed proximally. The lesion had never been treated. There was no history of any other cutaneous or systemic diseases. Similar disorder in the family was denied therefore we were not able to confirm it. On physical examination, the patient was in good health condition. Skin examination revealed reticulated brown-black pigmented macules on the dorsa of the hands and feet. Hair, facial skin, teeth, oral mucosa, and nails were normal. 
Discussion
Reticulate acropigmentation of Kitamura was first described by Akamatsu and Kitamura. About 100 cases have been reported, mostly in Asian ethnic groups. There is no sex predilection for RAPK. Many cases are familial, and the disorder is believed to be inherited as an autosomal dominant trait. Our patient was the only person affected in the family. It is very difficult to define the genetic background in our case, as we were unable to examine other family members. Hawsari et al 1 and Cox et al 2 also report a sporadic case of RAPK.
The cutaneous lesions of RAPK are asymptomatic. It has angular, irregular freckle-like lesion with atrophy on the surface, arranged in a reticulate pattern that develop on the dorsum of the hands and feet. It is usually manifest during childhood or in the first and second decades of life. The lesions are usually slowly darker over time. Sun exposure may aggravate the condition. The spots often increase in number and subsequently expand to proximal extremities and the trunk. Pits and breaks in the dermatoglyphics are found on the palms, soles and dorsal phalangeal surfaces. 3, 4 In our patient palmar pits and breaks in the epidermal ridge pattern were absent.
The pathogenesis is unknown. It has been postulated that an increased number of activated melanocytes and accelerated transfer of melanosomes to keratinocytes are responsible for the pigmented lesions. The origin of epidermal atrophy remains unclear. 5 Kono et al. 6 reported a mutation in ADAM10 encoding a zinc metalloprotease, a disintegrin and metalloprotease domain-containing protein 10 (ADAM10) was identified in the RAPK family. ADAM10 is known to be involved in the ectodomain shedding of various substrates in the skin.
Histopathological examination in RAPK classically shows epidermal atrophy associated with club-like elongation of the rete ridges and excess of melanin in the basal layer. 1 In our patient, histopathologic examination from the hyperpigmented lesions shows epidermal atrophy, digitate and filiform elongated rete ridges with clumps of heavy melanin pigmentation at their tips. 7 In our patient, we did not find any hypopigmentation lesion or freckles on the face. Examination of mucosa, hair, and nail did not reveal any abnormality.
Unfortunately, there are no effective treatment options for RAPK. Treatment with topical retinoids has been unsuccessful. 3 Adapalene provides only temporary improvement. Kameyama et al. 8 reported transient improvement of a patient with RAPK after using 20% azelaic acid. Q-switched alexandrite laser can be considered as a treatment option.
Farad et al. 9 successfully treated a patient with RAPK using a Q-switched alexandrite laser at 755 nm. The patient was almost recurrence-free after two years of followup. Unfortunately, our patient was lost to follow-up before receiving any treatment.
